Table 5.
Variables | Odds ratio | 95% confidence interval | p |
---|---|---|---|
Age ≥60 years | 0.202 | 0.06–0.675 | 0.009 |
SBP ≥ 125 mmHg | 2.942 | 1.021–8.480 | 0.046 |
Baseline TAPSE ≥16 mm | 3.744 | 1.054–13.3 | 0.041 |
ACE/ARBs maximum dose at baseline | 3.496 | 1.289–9.481 | 0.014 |
SBP, systolic blood pressure; TAPSE, tricuspid annular plane systolic excursion; ACEi/ARBs, angiotensin converting enzyme inhibitors/angiotensin receptor blockers. We have reported in bold the statistically significant P‐value.